The Texas Heart Institute has successfully implanted a BiVACOR Total Artificial Heart (TAH) in a patient with end-stage heart failure as a bridge to heart transplant. This solution is essentially a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart.
The first-in-human clinical study aims to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-transplant solution for patients with severe biventricular heart failure or univentricular heart failure, and four additional patients are scheduled to be enrolled in the study.
- Capture Stunning Footage - This vlogging camera features a 1-inch CMOS sensor and records in 4K resolution at an impressive 120fps. Capture...
- Effortlessly Frame Your Shots - Get the ideal composition with Osmo Pocket 3's expansive 2-inch touch screen that rotates for both horizontal and...
- Ultra-Steady Footage - Say goodbye to shaky videos. Osmo Pocket 3's advanced 3-axis mechanical stabilization delivers superb stability. Enjoy smooth...
The Texas Heart Institute is enthused about the groundbreaking first implantation of BiVACOR’s TAH. With heart failure remaining a leading cause of mortality globally, the BiVACOR TAH offers a beacon of hope for countless patients awaiting a heart transplant,” said Dr. Joseph Rogers, President and Chief Executive Officer of The Texas Heart Institute.
[Source]
